PKU brain study reveals how lowering phe levels may boost thinking
NCT ID NCT05356377
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 26 times
Summary
This study looked at how the drug Palynziq, which lowers phenylalanine levels in the blood, affects the brain and thinking skills in adults with PKU. Six participants had brain scans and took thinking and language tests after at least three months of treatment. The goal was to understand if reducing phenylalanine improves brain structure and function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
University of Missouri
Columbia, Missouri, 65211, United States
Conditions
Explore the condition pages connected to this study.